➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Harvard Business School
Express Scripts
Baxter
Merck

Last Updated: July 6, 2020

DrugPatentWatch Database Preview

Hydroxyzine pamoate - Generic Drug Details

» See Plans and Pricing

« Back to Dashboard

What are the generic sources for hydroxyzine pamoate and what is the scope of patent protection?

Hydroxyzine pamoate is the generic ingredient in three branded drugs marketed by Teva, Barr, Beximco Pharms Usa, Duramed Pharms Barr, Heritage Pharma, Impax Labs Inc, Ivax Sub Teva Pharms, Par Pharm, Sandoz, Superpharm, Vangard, Watson Labs, and Pfizer, and is included in thirty-seven NDAs. Additional information is available in the individual branded drug profile pages.

There are nineteen drug master file entries for hydroxyzine pamoate. Twenty-seven suppliers are listed for this compound.

Drug Prices for hydroxyzine pamoate

See drug prices for hydroxyzine pamoate

Drug Sales Revenue Trends for hydroxyzine pamoate

See drug sales revenues for hydroxyzine pamoate

Recent Clinical Trials for hydroxyzine pamoate

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Shalvata Mental Health CenterN/A

See all hydroxyzine pamoate clinical trials

Pharmacology for hydroxyzine pamoate
Drug ClassAntihistamine
Mechanism of ActionHistamine Receptor Antagonists

US Patents and Regulatory Information for hydroxyzine pamoate

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ivax Sub Teva Pharms HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 087760-001 Mar 5, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Barr HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 088488-001 Jun 15, 1984 RX No No   Start Trial   Start Trial   Start Trial
Duramed Pharms Barr HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 088594-001 Feb 29, 1984 DISCN No No   Start Trial   Start Trial   Start Trial
Par Pharm HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 087656-001 Jun 11, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Watson Labs HYDROXYZINE PAMOATE hydroxyzine pamoate CAPSULE;ORAL 087767-001 Aug 16, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Colorcon
Harvard Business School
Express Scripts
Baxter
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.